期刊文献+

4-[[4-氟-3-(4-丙基哌嗪-1-羰基)苄基]甲基]-2H-酞嗪-1-酮合成工艺研究

Synthesis of 4-[[4-Fluoro-3-(4-propylpiperazine-1-carbonyl)phenyl]methyl]-2H-phthalazin-1-one
下载PDF
导出
摘要 目的:对PARP抑制剂4-[[4-氟-3-(4-丙基哌嗪-1-羰基)苄基]甲基]-2H-酞嗪-1-酮的合成工艺进行了改进。方法:使用更为价廉的邻苯二甲酰亚胺作为起始原料,经选择性还原、加成、水解制得关键中间体2-氟-5-[(4-氧代-3,4-二氢酞嗪-1-基)甲基]苯甲酸,然后与1-叔丁氧羰基哌嗪缩合,卤代烃取代制得目标化合物。结果:用质谱、核磁共振氢谱确定了目标化合物的结构,总收率达30.4%。结论:与原工艺相比,该方法起始原料价廉易得,降低了成本,避免了大量的含碱废水,减少了环境污染。 The synthesis of the PARP Inhibitors4-(4-fluoro-3-(piperazine-1-carbonyl)benzyt)phthalazin-l(2H)-one was optimized. The key intermediate was prepared with Phthalimideas the starting material, by reduction, addition reaction, hydrolysis and 2-fluoro-5-[(4-oxo-3h-phthalazin-l-yl)methyl]Benzoie acid was obtained, and then the target compound was synthesized by the condensation of tert-butyl piperazine- 1-carboxylate with the key intermediate mentioned above, after substitution by halogenated hydrocarbons. The total yield was 30.4%. Structures of the target product and key intermediates were verified by MS and IHNMR.Compared with the original process, The optimal synthetic procedure with lower cost avoided the generation of a large amount of alkali-containing wastewater and reduced environmental pollution.
作者 焦淑艳 陈升 Jiao Shuyan, Chen Sheng(1. Quanzhou Vocational Education Center, Quanzhou 362000, 2. Fujian Architectural Institute of technology, Fuzhou 350002, Chin)
出处 《广东化工》 CAS 2018年第5期113-114,共2页 Guangdong Chemical Industry
关键词 PARP抑制剂 4-[4-氟-3-(哌嗪-1-羰基)苄基]-2H-酞嗪-1-酮 合成 PARP inhibitors 4-[[4-Fluoro-3-(4-propylpiperazine-1-carbonyl)phenyl]methyl]-2H-phthalazin-1-one synthesis
  • 相关文献

参考文献4

二级参考文献6

  • 1FDA. Lynparza [EB/OL]. [2014-12-19]. http://www. accessdata.fda.gov/drugsatfda--docs/label/2014/206162 lb 1. pdf.
  • 2钱祥军.奥拉帕尼及其类似物合成研究[D].南京:南京工业大学,2015:1-55.
  • 3Menear KA, Adcock C, Boulter R, et al. 4- [ 3- (4-Cyclopropanecarbonylpiperazine- 1 -carbonyl) -4- fluorobenzyl-2H-phthalazin-l-one: a novel bioavailable inhibitor of poly (ADP-ribose) polymerase-1 [J]. J Med Chem, 2008, 51 (20) : 658l 6591.
  • 4Menear KA, Ottridge AP, Londesbrough D J, et al. Phthalazinone derivatives: WO, 2008047082 [P]. 2008-04-24.
  • 5Isabel D, Sandra O, Christine P, et al. Process for preparing boronic acids and esters in the presence of magnesium metal: US, 20110282090 [P]. 2011-11-17.
  • 6Alice Chen.PARP inhibitors: its role in treatment of cancer[J].Chinese Journal of Cancer,2011,30(7):463-471. 被引量:19

共引文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部